Pharmacological chaperone reshapes the energy landscape for folding and aggregation of the prion protein
Small-molecule chaperones that can prevent protein misfolding have potential applications for treating diseases such as Alzheimer’s and ALS. Here the authors use high-resolution force spectroscopy to gain insight into the mechanism of action of an iron-tetrapyrrole with anti-prion properties.
Guardado en:
Autores principales: | Amar Nath Gupta, Krishna Neupane, Negar Rezajooei, Leonardo M. Cortez, Valerie L. Sim, Michael T. Woodside |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/abfdd6108de1499990d9c141d9020588 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacological inactivation of the prion protein by targeting a folding intermediate
por: Giovanni Spagnolli, et al.
Publicado: (2021) -
Metastatic breast cancer: Endocrine therapy landscape reshaped
por: Mohamad Adham Salkeni, et al.
Publicado: (2017) -
Protein folding while chaperone bound is dependent on weak interactions
por: Kevin Wu, et al.
Publicado: (2019) -
The mutational landscape of a prion-like domain
por: Benedetta Bolognesi, et al.
Publicado: (2019) -
Reshaping the phonon energy landscape of nanocrystals inside a terahertz plasmonic nanocavity
por: Xin Jin, et al.
Publicado: (2018)